Abstract
The liver is a frequent site for both primary cancers and metastases. While angiogenesis is essential for tumor growth, the specific response of the liver's specialized vascular zones to different cancer types remains poorly understood. Using single-cell RNA sequencing (scRNA-seq), this study characterizes the transcriptomic changes in liver endothelial cells (ECs) across mouse models of primary liver cancer and colorectal liver metastasis. The findings reveal that the host organ environment is the primary determinant of tumor endothelial cell (TEC) phenotype, overriding the influence of the tumor's origin. TECs exhibit a shift from sinusoidal to venous-like identities and form conserved "tip-like" and "stalk-like" clusters. Additionally, the study identifies a novel population of chimeric cells expressing both myeloid and endothelial markers, suggesting significant plasticity in the tumor microenvironment.
Introduction
The liver's unique immunological and vascular environment makes it a common host for both primary hepatocellular carcinoma and metastatic colorectal cancer. Tumors must hijack the blood supply to grow, a process known as angiogenesis. However, the liver's blood vessels are highly specialized and organized into distinct metabolic zones (portal vein, sinusoid, and central vein). It was previously unclear whether the tumor's origin dictates the nature of new blood vessel formation or if the liver environment forces all tumor vessels into a specific "liver-like" mold. Understanding these dynamics is crucial for developing targeted anti-angiogenic therapies that spare healthy tissue.
Methods
Researchers employed high-resolution single-cell technologies to dissect the liver's stromal environment in two mouse models: an inducible "spontaneous" liver cancer model (HDD-induced) and a human colorectal cancer metastasis model (HT-29 cells implanted in the liver). Using 10x Genomics scRNA-seq, they sequenced thousands of individual cells to identify gene expression patterns. Bioinformatics tools like Seurat and Monocle 2 were used for cell clustering and trajectory analysis. Findings were validated using RNAScope and immunohistochemistry (IHC) to visualize markers directly in tissue sections. The study also integrated baseline data from normal liver ECs across different mouse strains (C57BL/6 and SCID) and compared them with published datasets from other organs.
Results
The study yielded several key insights into the liver tumor microenvironment:
- Host Organ Dominance: One of the most significant findings is that TECs in the liver appear remarkably similar, regardless of whether the tumor originated in the liver or spread from the colon. The "liver-ness" of the host environment is a stronger determinant of vessel phenotype than the "colon-ness" of the original cancer.
- Vascular Identity Crisis and Zonal Disruption: Normal liver vessels are strictly zoned. Tumors disrupt this organization, causing ECs to lose their specialized sinusoidal markers and adopt a more "venous" (specifically portal vein-like) signature. Furthermore, tissue immediately surrounding a tumor—the "adjacent normal" tissue—exists in a transcriptional middle ground, with its gene expression already altered by the tumor's proximity.
- Conserved Angiogenic Programs: Similar to tumors in other organs, liver TECs differentiate into "tip-like" cells (leaders of new growth) and "stalk-like" cells (followers). These signatures, including genes like Dll4 and Aplnr, were highly conserved across different tumor types.
- Discovery of Chimeric Cells: The researchers identified a rare population (~5%) of cells expressing markers for both endothelial cells and myeloid cells (e.g., Kupffer cells or macrophages). These "Kupffer-ECs" and "Macrophage-ECs" suggest a high level of plasticity in the tumor microenvironment.
- Minimal Impact of Immune Status: Comparing immunocompetent and immunodeficient (SCID) mice revealed that while the immune system affects normal liver vessels (e.g., antigen presentation genes like Cd74), it has a minimal impact on the core transcriptome of tumor-associated vessels.
Specific markers like Lrg1 and Sema3d were found to be significantly upregulated in vessels near tumors, identifying them as potential targets for early-stage tumor-induced angiogenesis.
Discussion
While this study provides a high-resolution map of liver tumor vessels, several questions remain. The functional role of the newly identified chimeric cells is currently unknown—specifically, whether they physically integrate into vessel walls or serve a signaling function. Additionally, while the findings were benchmarked against human data, the primary results are in mouse models, necessitating further validation in human patients. Identifying genes uniquely expressed in liver TECs compared to normal liver zones offers promising avenues for developing more specific anti-angiogenic therapies.
Summary updated